Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

NCT05844384 is registered in ClinicalTrials.gov with 59th Medical Wing as lead sponsor.

NCT NCT05844384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05844384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
Lead sponsor
59th Medical Wing
Phase
Not applicable
Overall status
Recruiting
Start date
March 17, 2022
Completion date
March 17, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, primary open angle glaucoma